Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.
about
EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRCEpstein-Barr virus glycoprotein gH/gL antibodies complement IgA-viral capsid antigen for diagnosis of nasopharyngeal carcinoma.Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103.Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS.Effects of anti-CD44 monoclonal antibody IM7 carried with chitosan polylactic acid-coated nano-particles on the treatment of ovarian cancerBART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma.Direct targeting of MAPK8IP1 by miR-10a-5p is a major mechanism for gastric cancer metastasis.Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences.Pathobiologic Roles of Epstein-Barr Virus-Encoded MicroRNAs in Human Lymphomas.Deregulation of microRNA‑31a‑5p is involved in the development of primary hypertension by suppressing apoptosis of pulmonary artery smooth muscle cells via targeting TP53.Interplay of Viral Infection, Host Cell Factors and Tumor Microenvironment in the Pathogenesis of Nasopharyngeal Carcinoma.The emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinoma
P2860
Q36561585-852C4E15-A526-46A8-9938-D358F0EDF542Q37086039-D37F5788-D951-4F82-85D7-BB4639AFF9C8Q37330822-EC583B6C-0373-40D8-B308-98F3E684FE1AQ37392894-82A7618B-A9E5-4595-AC03-4B3598FA5A9FQ37594246-844C9379-5381-4C64-95BF-10B35DD5E44AQ37659154-68D76BB4-1D80-4EB7-8DFF-D9C768C748D0Q38689675-1ECD4B5E-FDE6-4D0C-803F-7266449E79B2Q38808086-B830449A-6CF2-4BE9-9208-9E7D77475C32Q53693461-A3FCCE56-9617-411B-B93D-94948D5822FAQ54241446-80300D3D-F39A-4493-AC6C-3624946B9FEEQ55313422-5B758BF0-49A9-435E-9723-EA411013504EQ56952019-AE078FA0-6DC9-445E-97DC-9A5E47E7F7EC
P2860
Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Gold nano-particles (AuNPs) ca ...... tive nasopharyngeal carcinoma.
@ast
Gold nano-particles (AuNPs) ca ...... tive nasopharyngeal carcinoma.
@en
type
label
Gold nano-particles (AuNPs) ca ...... tive nasopharyngeal carcinoma.
@ast
Gold nano-particles (AuNPs) ca ...... tive nasopharyngeal carcinoma.
@en
prefLabel
Gold nano-particles (AuNPs) ca ...... tive nasopharyngeal carcinoma.
@ast
Gold nano-particles (AuNPs) ca ...... tive nasopharyngeal carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Gold nano-particles (AuNPs) ca ...... tive nasopharyngeal carcinoma.
@en
P2093
Hongbing Cai
Jianguo Wang
Jinbang Li
Jinkun Liu
Longmei Cai
Xiaona Zhang
Yaoyong Lu
Yuxiang Chen
P2860
P304
P356
10.18632/ONCOTARGET.3046
P407
P50
P577
2015-04-01T00:00:00Z